Bevacizumab therapy for POEMS syndrome
Authors:
- Ashraf BadrosABAshraf Badros
- Neil PorterNPNeil Porter
- Ann ZimrinAZAnn Zimrin
- 1 August 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (3) , 1135
Abstract
A 52-year-old woman presented with progressive sensory and motor neuropathy for 2 years that left her bedridden. She had lost 30 kg and had a Karnofsky score of 40. She had received empiric intravenous immunoglobulin and steroids with no improvement. She was admitted with aspiration pneumonia. She had severe wasting and weakness in distal and proximal muscles, stocking-glove painful paresthesias, absent deep tendon reflexes, and weak gag reflex. She had extensive edema and hyperpigmented skin patches. She also had significant ascites, pleural and pericardial effusions, and hepatomegaly.Keywords
This publication has 6 references indexed in Scilit:
- The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implicationsBlood, 2005
- POEMS Syndrome and VEGFInternal Medicine, 2004
- POEMS Syndrome Demonstrating VEGF Decrease by TiclopidineInternal Medicine, 2004
- POEMS syndrome: definitions and long-term outcomeBlood, 2003
- Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in crow-fukase (POEMS) syndromeMuscle & Nerve, 1998
- Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndromeThe Lancet, 1996